Diagnostic and therapeutic strategies for invasive aspergillosis

Seminars in Respiratory and Critical Care Medicine

Volumn 18, Issue 3, 1997, Pages 203-215

  Verweij, Paul E ^b   Denning, David W ^a  

^a NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; FUNGUS ANTIBODY; FUNGUS ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; ITRACONAZOLE; VORICONAZOLE;

ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BRAIN INFECTION; CLINICAL FEATURE; CONFERENCE PAPER; DEBRIDEMENT; DIAGNOSTIC PROCEDURE; EXCISION; HUMAN; INCIDENCE; INTRAVENOUS DRUG ADMINISTRATION; LUNG ASPERGILLOSIS; MORTALITY; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION;

EID: 0030754154     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1070990     Document Type: Conference Paper

References (92)

1. Micheli PA. Nova plantarum genera juxta Tournefortil methodum disposita. Bernardo Paperini, Florence, 1729
2. Bennett JH. On the parasitic vegetable structures found growing in living animals. Trans Roy Soc Edinburgh 1842; 15:277-9
3. Rankin NE. Disseminated aspergillosis and momliasis associated with agranulocytosis and antibiotic therapy. Br Med J 1953;25:918-19
4. Keye JD, Magee WE Fungal diseases in a general hospital. Am J Clin Pathol 1956;26:1235-53
5. Young RC, Bennett JE, Vogel CL, Carbone PP, DeVita VT Aspergillosis the spectrum of disease in 98 patients. Medicine 1970;49:147-73
6. Denning DW, Lee JY, Hosteller JS, et al. NIAID Mycoses Study Group multicenter trial of oral itraconazole therapy of invasive aspergillosis. Am J Med 1994;97:135-14
7. Bodey G, Bueltmann B, Duguid W, et al. Fungal infections in cancer patients: an international autopsy survey. Eur J Clin Microbiol Infect Dis 1992;11:99-109
8. Groll AH, Shah PM, Mentzel C, Schneider M, Just-Nuebling G, Huebner K. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 1996;33:23-32
9. Ritter J, Roos N. Special aspects related to invasive fungal infections in children with cancer. In Meunier F ed. Clinical Infectious Diseases: Invesive Fungal Infections in Cancer Patients. London, Philadelphia, Sydney, Tokyo, Toronto, Balliere Tindall, 1995; 179-204
10. Gonzalez-Crespo MR, Gomez-Reino JJ. Invasive aspergillosis in systemic lupus erythematosus. Sem Arth Rheum 1995; 24:304-14
11. Gerson SL, Talbot GH, Hurwitz S, Strom BL, Lusk EJ, Cassileth PA. Prolonged granulocytopenia: The major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia Ann Intern Med 1984;100:345-51
12. Mouy R, Fischer A, Vilmer E, Seger R, Griscelli C. Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr 1989;114:555-60
13. Gustafson TL, Schaffner W, Lavely GB, Stratton CW, Johnson HK, Hutcheson RH. Invasive aspergillosis in renal transplant recipients: Correlation with corticosteroid therapy. J Infect Dis 1983;148:230-4
14. McWhinney PHM, Kibbler CC, Hamon MD, et al. Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: thirteen years experience. Clin Infect Dis 1993;17:397-404
15. Khoo S, Denning DW. Aspergillus infection in the acquired immune deficiency syndrome. Clin Infect Dis 1984; 19 (Suppl 1): 541-8
16. Martino P, Raccah R, Gentile G, et al. Aspergillus colonization of the nose and pulmonary aspergillosis in neutropenic patients: a retrospective study. Haematologica 1989;74: 263-5
17. Flume PA, Egan TM, Paradowski LJ, Detterbeck FC, Thompson JT, Yankaskas JR. Infectious complications of lung transplantation. Impact of cystic fibrosis. Am J Respir Crit Care Med 1994;149:1601-7
18. Guillemain R, Lavarde V, Amrein C, Chevalier P, Guinvarc'h A, Glotz D. Invasive aspergillosis after transplantation. Trans Proc 1995;27:1307-9
19. Schaffner A, Douglas H, Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. J Clin Invest 1982;69:617-31
20. Roilides E, Unlig K, Venzon D, Pizzo PA, Walsh TJ. Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma Interferon. Infect Immun 1993;61:4870-7
21. Ng TTC, Robson GD, Denning DW. Hydrocortisone-enhanced growth of Aspergillus spp., implications for pathogenesis. Microbiology 1994;140:2475-80
22. Pagano L, Ricci P, Nosari A, et al. The Gimema Infection Program: Fatal haemoptysis in pulmonary filamentous mycosis: an underevaluated cause of death in patients with acute leukaemia in haematological complete remission. A retrospective study and review of the literature. Br J Haematol 1995;89:500-5
23. Martino P, Girmenia C, Venditti M, et al. Spontaneous pneumothorax complicating pulmonary mycetoma in patients with acute leukemia Rev Infect Dis 1990;12:611-17
24. Miller WT Jr, Sais GJ, Frank I, Gefter WB, Aronchick JM, Miller WT. Pulmonary aspergillosis in patients with AIDS. Clinical and radiographic correlations. Chest 1994;105: 37-44
25. Sallustio G, Pagano L, Barbera EOL, et al. Pulmonary aspergillosis in patients with hematologic malignancies: clinicoradiologic correlation Rays 1994;19:465-78
26. Kuhlman JE, Fishman EK, Siegelman SS. Invasive pulmonary aspergillosis in acute leukemia: Characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis. Radiology 1985;157:611-14
27. Mori M, Galvin JR, Barloon TJ, Gingrich RD, Stanford W. Fungal pulmonary infections after bone marrow transplantation: Evaluation with radiography and CT Radiology 1991;178:721-6
28. Pasmans HLM, Loosbeld OJL, Schouten HC, Thunnissen F, van Engleshoven JMA. Invasive aspergillosis in immunocompromised patients: findings on plain film and (HR)CT. EurJ Radiol 1992;14:37-40
29. von Eiff M, Zühlsdorf M, Roos N, Hesse M, Schulten R, van de Loo J. Pulmonary fungal infections in patients with hematological malignancies-diagnostic approaches. Ann Hematol 1995;70:135-41
30. Logan PM, Primack SL, Staples C, Miller RR, Müller NL. Acute lung disease in the immunocompromised host. Chest 1995;108:1283-7
31. Kibbler CC, Milkins SR, Bhamra A, Spiteri MA, Noone P, Prentice HG. Apparent pulmonary mycetoma following invasive aspergillosis in neutropenic patients. Thorax 1988;43:108-12
32. Orr DP, Myerowm RL, Dubois PJ. Patho-radiologic correlation of invasive pulmonary aspergillosis in the compromised host. Cancer 1978;41:2028-39
33. Caillot D, Casasnovas O, Bernard A, et al. Improved management of invasive aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997;15:139-47
34. Pai H, Blinkhorn RJ, Tomashefski JF. Invasive cavitary pulmonary aspergillosis in patients with cancer: A clinicopathological study. Hum Pathol 1994;25:293-303
35. Haramati LB, Schulman LL, Austin JHM. Lung nodules and masses after cardiac transplantation. Radiology 1993;188; 491-7
36. End A, Helbich T, Wisser W, Dekan G, Klepetko W. The pulmonary nodule after lung transplantation. Chest 1995; 107:1317-22
37. Denning DW, Follansbee S, Scolaro M, Norris S, Edelstein D, Stevens DA. Pulmonary aspergillosis in AIDS. N Engl J Med 1991;324:654-62
38. Staples CA, Kang E-Y, Wright JL, Phillips P, Müller NL. Invasive pulmonary aspergillosis in AIDS: radiographic, CT, and pathologic findings. Radiology 1995;196:409-14
39. Lortholary O, Meyohas M-C, Dupont B, et al. Invasive aspergillosis in patients with acquired immunodeficiency syndrome: Report of 33 cases. Am J Med 1993;95:177-87
40. Kramer MR, Denning DW, Marshall SE, et al. Ulcerative tracheobronchitis following lung transplantation: a new form of invasive aspergillosis. Am Rev Respir Dis 1991;144: 552-6
41. Kemper CA, Hosteller JS, Follansbee S, et al. Ulcerative and plaque-like tracheobronchitis due to infection with Aspergillus in patients with AIDS. Clin Infect Dis 1993;17: 344-52
42. Kac G, Roux P, Poirot JL, et al. Aspergillus et aspergilloses: Étude rétrospective dans deux hôpitaux parisiens. J Mycol Med 1995;5:75-85
43. Talbot GH, Huang A, Provencher M. Invasive Aspergillus rhinosinusitis in patients with acute leukemia. Rev Infect Dis 1991;13:219-32
44. Drakos PE, Nagler A, Or R, et al. Invasive fungal sinusitis in patients undergoing bone marrow transplantation. Bone Marrow Transplant 1993;12:203-8
45. Martinez AJ, Ahdab-Barmada M. The neuropathology of liver transplantation: Comparison of main complications in children and adults. Mod Pathol 1993;6:25-32
46. Hagensee ME, Bauwens JE, Kjos B, Bowden RA. Brain abscess following marrow transplantation: Experience at the Fred Hutchinson Cancer Research Center, 1984-1992. Clin Infect Dis 1994;19:402-8
47. Boes B, Bashir R, Boes C, Hahn F, McConnell JR, McComb R. Central nervous system aspergillosis. J Neuroimaging 1994;4:123-9
48. Walsh TJ, Hier DB, Caplan LR. Aspergillosis of the central nervous system: Clinicopathological analysis of 17 patients. Ann Neurol 1985;18:574-82
49. Monod M, Baudraz-Rosselet F, Ramelet AA, Frenk E. Direct mycological examination in dermatology a comparison of different methods Dermatologica 1989;179:183-6
50. Denning DW, Marinus A, Cohen J, et al Risk factors and outcome from invasive Aspergillosis (LA). 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, Louisiana, 1996
51. Denning DW. Diagnosis and management of invasive aspergillosis. In Remington J, Schwartz MN eds. Current Clinical Topics in Infectious Diseases. Blackwell, 1996: 277-301
52. Horvath JA, Dummer S. The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am J Med 1996;100:171-8
53. Barries AJ, Denning DW. Aspergillus - significance as a pathogen. Rev Med Microbiol 1993;4:176-80
54. Duthie R, Denning DW. Aspergillus fungemia. Two cases and review. Clin Infect Dis 1995;20:598-605
55. Martino P, Girmenia C, Micozzi A. et al. Fungemia in patients with leukemia. Am J Med Sci 1993;306:225-32
56. Reddy LV, Kumar A, Kurup VP. Specific amplification of Aspergillus fumigatus DNA by polymerase chain reaction. Mol Cell Probes 1993;7:121-26
57. Tang CM, Holden DW, Aufauvre-Brown A, Cohen J. The detection of Aspergillus spp by the polymerase chain reaction and its evaluation in bronchoalveolar lavage fluid. Am Rev Respir Dis 1993;148:1313-7
58. Melchers WJG, Verweij PE, Van Der Hurk P, et al. General primer-mediated PCR for detection of Aspergillus species. J Clin Microbiol 1994;32:1710-17
59. Bretagne S, Costa JM, Marmorat-Khuong A, et al. Detection of Aspergillus DNA in bronchoalveolar lavage samples by competitive PCR. J Clin Microbiol 1995;33:1164-8
60. Makimura K, Murayama SY, Yamaguchi H. Detection of a wide range of medically important fungi by the polymerase chain reaction. J Med Microbiol 1994;40:358-64
61. Haynes KA, Westereng TJ, Fell JW, Moeris W. Rapid detection and identification of pathogenic fungi by polymerase chain reaction amplification of large subunit ribosomal DNA. J Med Vet Mycol 1995;33:319-25
62. Walsh TJ, Francesconi A, Kasai M, Chanock SJ. PCR and single-strand conformational polymorphism for recognition of medically important opportunistic fungi. J Clin Microbiol 1995;33:3216-20
63. Tomee JF, Mannes GP, van der Bij W, et al. Serodiagnosis and monitoring of Aspergillus infections after lung transplantation. Ann Intern Med 1996;125:197-201
64. Sulahm A, Talbot M, Ribaud P, et al. Comparison of an enzyme linked immunoassay and latex agglutination test for detection of galactomannan in the diagnosis of invasive aspergiliosis. EurJ Clin Microbiol Infect Dis 1996;15:139-45
65. Verweij PE, Rijs AJMM, De Pauw BE, Horrevorts AM, Hoogkamp-Korstanje JAA, Meis JFGM. Clinical evaluation and reproducibility of the Pastorex Aspergillus antigen latex agglutination test for diagnosing invasive aspergillosis. J Clin Pathol 1995;48:474-6
66. Dupont B, Improvisi L, Provost F. Détection de galactomannane dans les aspergillosis invasives humaines et animales avec un test au latex Bull Soc Fr Mycol Med 1990;19: 464-70
67. Stynen D, Goris A, Sarfati J. Latgé JP. A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis. J Clin Microbiol 1995;33:497-500
68. Verweij PE, Stynen D, Rijs AJMM, De Pauw BE, Hoogkamp-Korstanje JAA, Meis JFGM. Sandwich enzyme-linked immunosorbent assay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients. J Clin Microbiol 1995;33: 1912-14
69. Rohrlich P, Sarfati J, Mariani P, et al Prospective sandwich enzyme linked immunosorbent assay for serum galactomannan: early predictive value and clinical use in invasive aspergillosis. Pediatr Infect Dis J 1996;15:232-7
70. Verweij PE, Latgé JP, Rijs AJMM, et al. Comparison of antigen detection and PCR assay using bronchoalveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies. J Clin Microbiol 1995;33:3150-3
71. Verweij PE, Dompeling EC, Donnelly JP, Schattenberg AVMB, Meis JFGM. Serial monitoring of Asprrgillus antigen in the early diagnosis of invasive aspergillosis. Preliminary investigations with two examples. Infection 1997;
72. Swanink CMA, Meis JFGM, Rijs AJMM, Donnelly JP, Verweij PE. Specificity of a sandwich enzyme linked immunosorbent assay for detecting Aspergillus galactomannan. J Clin Microbiol 1997;35:257-60
73. Obayashi T, Yoshida M, Tamura H, Aketagawa J, Tanaka S, Kawai T. Determination of plasma (1,3)-ß-D-glucan: a new diagnostic aid to deep mycosis. J Med Vet Mycol 1992;30: 275-80
74. Obayashi T, Yoshida M, Mori T, et al. Plasma (1,3)-ß-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995;345:17-20
75. von Eiff M, Roos N, Schulten R, Hesse M, Zûhlsdorf M, van de Loo J. Pulmonary aspergillosis: Early diagnosis improves survival. Respiration 1995;62:341-7
76. Denning DW. The treatment of invasive aspergillosis. J Infect 1994;28(Suppl 1):25-33
77. Denning DW, Venkateswarlu K, Oakley KI., et al. Itracoriazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother 1997; June
78. Denning DW, Radford SA, Oakley KL, Hall L, Johnson EM, Warnock DW. Correlation between in vitro susceptibility-testing to itraconazole and in vivo outcome of Aspergillus fumigatus infection. J Antimicrob Chemother
79. Oakley KL, Moore CB, Denning DW. In vitro activity of voriconazole against Aspergillus spp. and comparison with amphotericin B and itraconazole [Abstract F81]. Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, September 1996; 114
80. Denning DW. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis 1996;23:608-15
81. Sanchez C, Mauri E, Dalmau D, Quintana S, Aparicio A, Garau J. Treatment of cerebral aspergillosis with itraconazole: Do high doses improve the prognosis? Clin Infect Dis 1995;21:1485-7
82. Hiemenz JW, Walsh TJ. Lipid formulations of amphotericin B: recent progress and future directions. Clin Infect Dis 1996;22(Suppl 2):S133-44
83. Ellis M, Spence D, Meunier F, et al. EORTC IFICG: Randomised multicentre trial of 1 mg/kg (LD) versus 4 mg/kg (HD) liposomal amphotericin B (AmBisome) (LAB) in the treatment of invasive aspergillosis (IA). 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, Louisiana, 1996
84. Stevens DA. Overview of amphotericin B colloidal dispersion (Amphocil). J Infect 1994;28(Suppl 1):S45-9
85. Meunier F, Prentice HG, Ringden O. Liposomal amphotericin B (Ambisome) safety data from a phase II/III clinical trial. J Antimicrob Chemother 1991;28(Suppl B): S83-91
86. Mills W, Chopra R, Linch DC, et al. Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single-centre experience of 133 episodes in 116 patients. Br J Haematol 1994;86:754-60
87. Oppenheim BA, Herbrecht R, Kusne S. The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses. Clin Infect Dis 1995;21: 1145-53
88. Denning DW, Del Favero A, Gluckman E, et al. UK-109,496, a novel, wide-spectrum triazole derivative for the treatment of fungal infections: Clinical efficacy in acute invasive aspergillosis [Abstract F80]. Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, September 1995; 126
89. Martino R, Nomdedéu J, Altés, Sureda A, Brunet S, Martinez C, Domingo-Albós A. Successful bone marrow transplantation in patients with previous invasive fungal infections: report of four cases. Bone Marrow Transplant 1994;13: 265-9
90. Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2121 published cases. Rev Infect Dis 1990;12:1147-1201
91. Robinson LA, Reed EC, Galbraith TA, Alonso A, Moulton AL, Fleming WH. Pulmonary resection for invasive Aspergillus infections in immunocompromised patients. J Thorac Cardiovasc Surg 1995;109:1182-97
92. Ribrag V, Dreyfus F, Venot A, Leblong V, Lanore JJ, Varet B. Prognostic factors of invasive pulmonary aspergillosis in leukemic patients. Leuk Lymph 1993;10:317-21